Ionis Pharmaceuticals Inc Neurological Disease Franchise Webcast Transcript
Good afternoon and welcome to the Ionis Pharmaceuticals neurological disease pipeline webcast. As a reminder, this webcast is being recorded.
At this time, I would now like to turn conference over to Wade Walke, Vice President of Investor Relations. Wade, please begin.
Thank you, Karl. Before we begin, I encourage everyone who's not yet launched the webcast to proceed to the investor section of the Ionis website and find a link to this webcast and the related slides.
I would like to draw your attention to Slide 2, which contains our forward-looking language statement. We'll be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties and our actual results may differ materially, and created to consult the risk factors discussed in our SEC filings for additional detail.
And with that, I'll turn the call over to Dr. Stan Crooke, CEO and Chairman at Ionis.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |